A Prospective, Multicenter Study to Investigate the Pharmacokinetics, Safety, and Efficacy of Cadazolid Versus Vancomycin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea
Phase of Trial: Phase II/III
Latest Information Update: 29 Nov 2017
At a glance
- Drugs Cadazolid (Primary) ; Vancomycin
- Indications Clostridium infections; Diarrhoea
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Actelion Pharmaceuticals
- 22 Nov 2017 Status changed from recruiting to suspended.
- 03 May 2017 Planned End Date changed from 1 Jun 2021 to 22 Mar 2021.
- 03 May 2017 Planned primary completion date changed from 1 Jun 2021 to 2 Mar 2021.